Skip to main content

Table 1 Demographic characteristics of patients with acute coronary syndrome in selected studies

From: Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention

 Velders et al.Ianaccone et al.Wang et al.Kurisu et al.Rohrmann et al.Gong et al.
Characteristics, n (%)Cancer
n = 208
No cancer
n = 3215
Cancer
n = 858
No cancer
n = 13,773
Cancer
n = 263
No cancer
n = 2083
Cancer
n = 18
No cancer
n = 59
Cancer
n = 1981
No cancer
n = 1981
Cancer
n = 22,907
No cancer
n = 247,182
Age (years)69.6 ± 1162.8 ± 12.470.8 ± 10.362.8 ± 12.672.0 ± 10.763.3 ± 13.770.4 ± 8.168.8 ± 11.873.1 ± 11.673.1 ± 10.9n/an/a
Men141 (67.8)2427 (75.5)612 (71.3)10,633 (77.2)178 (67.7)1480 (71.1)13 (72.2)44 (74.6)1432 (72.3)1443 (72.8)13,996 (61.1)153,747 (62.2)
Systemic hypertension88 (42.7)1135 (35.4)558 (65)7961 (57.8)199 (75.7)1429 (68.5)11(61.1)37 (62.7)1309/1879 (69.7)1313/1878 (69.9)13,790 (60.2)147,568 (59.7)
Diabetes mellitus23 (11)361 (11.2)246 (28.7)3237 (23.5)44 (16.7)381 (18.3)7 (38.9)25 (42.4)439/1894 (23.2)476/1890 (25.2)6849 (29.9)72,177 (29.2)
Hyperlipidemia46 (22.4)738 (23.1)414 (48.2)7327 (53.2)186 (70.7)1536 (73.7)n/an/a974/1704 (57.2)1033/1737 (59.5)8980 (39.2)97,390 (39.4)
Active smoker61 (31)1487 (46.8)n/an/a169 (64.3)1422 (68.3)n/an/a456/1728 (26.4)494/1733 (28.5)n/an/a
History of
 Myocardial infarction35 (17)335 (10.4)132 (15.4)1584 (11.5)44 (16.7)301 (14.5)n/an/a444/1981 (22.4)404/1981 (20.4)n/an/a
 PCI21 (10.2)267 (8.3)125 (14.6)1708 (12.4)55 (20.9)330 (15.8)n/an/an/an/a916 (4)9640 (3.9)
 CABG5 (2.4)79 (2.5)40 (4.7)427 (3.1)32 (12.2)146 (7)n/an/an/an/an/an/a
 Stroke24 (11.7)191 (5.9)71 (8.3)744 (5.4)39 (14.8)161 (7.7)n/an/a164/1981 (8.3)153/1981 (7.7)1558 (6.8)15,573 (6.3)
 Anemia53 (11.8)152 (5.2)n/an/an/an/a9 (50)4 (6.8)312/807 (38.7)192/777 (24.7)4971 (21.7)49,931 (20.2)
Clinical presentation
 STEMI208 (100)3215 (100)440 (51.3)8043 (58.4)263 (100)2083 (100)n/an/a1033/1981 (52.1)987/1981 (49.8)n/an/a
 NSTEMI00279 (32.5)3912 (28.4)00n/an/an/an/an/an/a
 Unstable angina00139 (16.2)1818 (13.2)00n/an/an/an/an/an/a
Number of diseased vessels
 1 vessel87 (41.8)1522 (47.4)n/an/a244 (92,8)1959 (94)9 (50)35 (59.3)n/an/an/an/a
 2 vessels71 (34.1)1005 (31.3)n/an/a19 (7.2)119 (5.7)7 (38.9)17 (28.8)n/an/an/an/a
 3 vessels50 (24)685 (21.3)n/an/a05 (0.2)2 (11.1)7 (11.9)n/an/an/an/a
Procedure
 Stenting192 (92.3)3082 (95.9)812 (94.6)13,332 (96.8)n/an/a16 (88.9)54 (91.5)n/an/an/an/a
 Drug-eluting stent124 (60.8)2263 (70.8)304 (35.4)5523 (40.1)110 (41.8)1138 (54.6)1 (5.6)7 (11.9)n/an/an/an/a
 Bare metal stent67 (32.8)812 (25.4)508 (59.2)7809 (56.7)n/an/a15 (83.3)47 (79.7)n/an/an/an/a
Treatments at discharge
 Beta-blockers160 (84.2)2812 (90.5)640 (74.6)11,198 (81.3)n/an/a2 (14.3)27 (48.2)1183/1960 (60.4)1192/1957 (60.9)7193 (31.4)75,638 (30.6)
 ACE/ARBs139 (73.2)2220 (71.5)605 (70.6)10,344 (75.1)n/an/a6 (42.9)43 (76.8)995/1961 (50.7)1038/1962 (52.9)8705 (38)90,963 (36.8)
 Statins171 (90)2897 (93.2)780 (90.9)12,878 (93.5)n/an/a8 (57.1)41 (73.2)1322/1958 (67.5)1384/1965 (70.4)5933 (25.9)62,537 (25.3)
 Aspirin187 (98.4)3097 (99.3)850 (99.1)13,690 (99.4)n/an/a13 (92.9)56 (100)1829/1973 (92.7)1858/1975 (94.1)n/an/a
 P2Y12 inhibitors186 (97.9)3058 (98)766 (89.3)11,996 (87.1)n/an/an/an/a1380/1963 (70.3)1465/1971 (74.3)962 (4.2)10,135 (4.1)
  1. ACE Angiotensin-Converting Enzyme; ARBs Angiotensin Receptor Blockers; CABG Coronary Artery Bypass Grafting; NSTEMI Non ST-Elevation Myocardial Infarction; PCI Percutaneous Coronary Intervention; STEMI ST-Elevation Myocardial Infarction; n/a not available